New Enterprise Associates

News, insights, analysis and data

← Back to New Enterprise Associates profile

New Enterprise Associates related stories

All articles and analysis

  • Week in deals, Jan. 12, 2009
    Brad Meikle- 12 January 2009

    Summary of tech companies and other businesses that raised financing in North America in the past week

  • Exit watch, week of Jan. 12, 2009
    Brad Meikle- 12 January 2009

    News briefs about Force 10, Premise and other VC-backed companies that have been bought or merged in the past two weeks

  • PE Week Wire: Monday, January 12, 2009
    Brad Meikle- 12 January 2009

    Random Ramblings

  • PE Week Wire: Monday, January 12, 2009
    Brad Meikle- 12 January 2009

    Random Ramblings

  • SolFocus Raises $47.5 Million
    VCJ Staff- 9 January 2009

    SolFocus Inc., a Palo Alto, Calif.-based developer of solar concentrator photovoltaic systems, has raised $47.5 million in Series C funding. Apex Venture Partners led the round, and was joined by return backers like New Enterprise Associates and NGEN Partners. It had previously raised nearly $100 million. The company also announced that it has named president Mark Crowley as its new CEO.

  • PE Week Wire: Friday, January 9, 2009
    Brad Meikle- 9 January 2009

    Friday Feedback

  • PE Week Wire: Friday, January 9, 2009
    Brad Meikle- 9 January 2009

    Friday Feedback

  • Concentric Medical Raises $15 Million
    VCJ Staff- 8 January 2009

    Concentric Medical Inc., a Mountain View Calif.-based developer of medical devices for restoring blood flow in people who have suffered ischemic strokes, has raised $15 million in new VC funding led by existing backer New Enterprise Associates. The company had previously raised around $53 million from firms like NEA, SV Life Sciences, Oxford Bioscience Partners and ProQuest Investments. Last February, Concentric Medical canceled a proposed $69 million IPO.

  • Satori Pharma Raises $22 Million
    VCJ Staff- 8 January 2009

    Satori Pharmaceuticals Inc., a Cambridge, Mass.-based developer of therapeutics for neurodegenerative disorders like Alzheimer's disease and Parkinson's disease, has raised $22 million in Series B funding. InterWest Partners, Prospect Venture Partners and New Enterprise Associates co-led the round, and were joined by return backers like PureTech Ventures. In other Satori news, the company named former Pfizer exec Jeffrey Ives as CEO.

  • PE Week Wire: Thursday, January 8, 2009
    Brad Meikle- 8 January 2009

    49,000 and Counting